Charles River Laboratories International Inc (NYSE: CRL) is -9.93% lower on its value in year-to-date trading and has touched a low of $159.65 and a high of $275.00 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CRL stock was last observed hovering at around $165.87 in the last trading session, with the day’s gains setting it 0.4%.
Currently trading at $166.27, the stock is -2.01% and -9.02% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.05 million and changing 0.24% at the moment leaves the stock -17.59% off its SMA200. CRL registered -23.59% loss for a year compared to 6-month loss of -27.33%. The firm has a 50-day simple moving average (SMA 50) of $183.322 and a 200-day simple moving average (SMA200) of $202.0611.
The stock witnessed a -12.28% gain in the last 1 month and extending the period to 3 months gives it a -8.88%, and is 0.42% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.73% over the week and 3.06% over the month.
Charles River Laboratories International Inc (CRL) has around 21800 employees, a market worth around $8.50B and $4.06B in sales. Current P/E ratio is 20.53 and Fwd P/E is 17.03. Profit margin for the company is 10.31%. Distance from 52-week low is 4.15% and -39.54% from its 52-week high. The company has generated returns on investments over the last 12 months (6.40%).
The EPS is expected to shrink by -4.54% this year
912.0 institutions hold shares in Charles River Laboratories International Inc (CRL), with institutional investors hold 103.69% of the company’s shares. The shares outstanding are 51.13M, and float is at 50.59M with Short Float at 4.26%. Institutions hold 102.75% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 6.1 million shares valued at $1.26 billion. The investor’s holdings represent 11.8396 of the CRL Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.09 million shares valued at $1.05 billion to account for 9.8699 of the shares outstanding. The other top investors are STATE STREET CORP which holds 2.09 million shares representing 4.052 and valued at over $431.52 million, while KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC holds 3.7031 of the shares totaling 1.91 million with a market value of $394.36 million.
Charles River Laboratories International Inc (CRL) Insider Activity
The most recent transaction is an insider sale by WALLMAN RICHARD F, the company’s Director. SEC filings show that WALLMAN RICHARD F sold 6,621 shares of the company’s common stock on Nov 07 ’24 at a price of $216.12 per share for a total of $1.43 million. Following the sale, the insider now owns 12386.0 shares.
Charles River Laboratories International Inc disclosed in a document filed with the SEC on Nov 07 ’24 that WALLMAN RICHARD F (Director) sold a total of 1,000 shares of the company’s common stock. The trade occurred on Nov 07 ’24 and was made at $216.50 per share for $0.22 million. Following the transaction, the insider now directly holds 0.0 shares of the CRL stock.
Still, SEC filings show that on Nov 07 ’24, WALLMAN RICHARD F (Director) Proposed Sale 12,161 shares at an average price of $216.01 for $2.63 million. The insider now directly holds shares of Charles River Laboratories International Inc (CRL).
